William J. Link Ph.D., Director at Tarsus Pharmaceuticals, Inc. (TARS), sold 12,500 shares at $78.33 ($980K) on 2026-09-15, disclosed to the SEC on 2026-09-17.
Scheduled sale ($980k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $78.33 | 11,675 | $915K | 93.3% |
| 2 | $79.00 | 759 | $60K | 6.1% |
| 3 | $80.01 | 66 | $5K | 0.5% |
| Total | $78.38 avg | 12,500 | $980K | 100% |
| Filing → |
| TARS | SELL | 2025-12-17 | $3.3M | — | Filing → |
| TARS | SELL | 2025-09-10 | $1.5M | — | Filing → |
| TARS | SELL | 2024-08-14 | $1.8M | — | Filing → |